A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy
Condition: NSAID-induced GastropathyInterventions: Drug: bismuth tripotassium dicitrate; Drug: pantoprazoleSponsor: Astellas Pharma Europe B.V.Not yet recruiting - verified May 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 27, 2016 Category: Research Source Type: clinical trials